BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 16987826)

  • 21. Early immune events in scleroderma.
    Postlethwaite AE
    Rheum Dis Clin North Am; 1990 Feb; 16(1):125-39. PubMed ID: 2406803
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potential immunologic targets for treating fibrosis in systemic sclerosis: a review focused on leukocytes and cytokines.
    Hasegawa M; Takehara K
    Semin Arthritis Rheum; 2012 Dec; 42(3):281-96. PubMed ID: 22542279
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endothelin receptor selectivity: evidence from in vitro and pre-clinical models of scleroderma.
    Shiwen X; Leask A; Abraham DJ; Fonseca C
    Eur J Clin Invest; 2009 Jun; 39 Suppl 2():19-26. PubMed ID: 19335743
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-topoisomerase I autoantibodies in systemic sclerosis.
    Czömpöly T; Simon D; Czirják L; Németh P
    Autoimmun Rev; 2009 Jul; 8(8):692-6. PubMed ID: 19393194
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunology of systemic sclerosis.
    Artlett CM
    Front Biosci; 2005 May; 10():1707-19. PubMed ID: 15769660
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanisms and consequences of fibrosis in systemic sclerosis.
    Denton CP; Black CM; Abraham DJ
    Nat Clin Pract Rheumatol; 2006 Mar; 2(3):134-44. PubMed ID: 16932673
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The microvascular endothelium in scleroderma.
    Kahaleh B
    Rheumatology (Oxford); 2008 Oct; 47 Suppl 5():v14-5. PubMed ID: 18784128
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The lung megakaryocytes and pulmonary fibrosis in systemic sclerosis.
    Thachil J
    Med Hypotheses; 2009 Mar; 72(3):291-3. PubMed ID: 19036527
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship between cytokine profiles and clinical outcomes in patients with systemic sclerosis.
    Baraut J; Michel L; Verrecchia F; Farge D
    Autoimmun Rev; 2010 Dec; 10(2):65-73. PubMed ID: 20713187
    [TBL] [Abstract][Full Text] [Related]  

  • 30. B lymphocytes in systemic sclerosis: Abnormalities and therapeutic targets.
    Yoshizaki A
    J Dermatol; 2016 Jan; 43(1):39-45. PubMed ID: 26782005
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of interferon-alpha by scleroderma sera containing autoantibodies to topoisomerase I: association of higher interferon-alpha activity with lung fibrosis.
    Kim D; Peck A; Santer D; Patole P; Schwartz SM; Molitor JA; Arnett FC; Elkon KB
    Arthritis Rheum; 2008 Jul; 58(7):2163-73. PubMed ID: 18576347
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systemic sclerosis and infections.
    Randone SB; Guiducci S; Cerinic MM
    Autoimmun Rev; 2008 Oct; 8(1):36-40. PubMed ID: 18706530
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of IL-13 in systemic sclerosis.
    Fuschiotti P
    Cytokine; 2011 Dec; 56(3):544-9. PubMed ID: 21920770
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathogenic roles of B lymphocytes in systemic sclerosis.
    Yoshizaki A
    Immunol Lett; 2018 Mar; 195():76-82. PubMed ID: 29307688
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathogenesis and therapeutic approaches for improved topical treatment in localized scleroderma and systemic sclerosis.
    Badea I; Taylor M; Rosenberg A; Foldvari M
    Rheumatology (Oxford); 2009 Mar; 48(3):213-21. PubMed ID: 19022832
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Systemic sclerosis: an update.
    Varga J
    Bull NYU Hosp Jt Dis; 2008; 66(3):198-202. PubMed ID: 18937632
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Do infections facilitate the emergence of systemic sclerosis?
    Grossman C; Dovrish Z; Shoenfeld Y; Amital H
    Autoimmun Rev; 2011 Mar; 10(5):244-7. PubMed ID: 20863912
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monocyte chemoattractant proteins in the pathogenesis of systemic sclerosis.
    Distler JH; Akhmetshina A; Schett G; Distler O
    Rheumatology (Oxford); 2009 Feb; 48(2):98-103. PubMed ID: 18984611
    [TBL] [Abstract][Full Text] [Related]  

  • 39. T cell abnormalities in systemic sclerosis with a focus on Th17 cells.
    Brembilla NC; Chizzolini C
    Eur Cytokine Netw; 2012; 23(4):128-39. PubMed ID: 23360781
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Humoral and cellular immunity in progressive systemic sclerosis.
    Sierakowski S; Bernacka K
    Med Interne; 1987; 25(4):233-8. PubMed ID: 3501150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.